630 related articles for article (PubMed ID: 16889573)
21. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
[TBL] [Abstract][Full Text] [Related]
22. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M
Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
[TBL] [Abstract][Full Text] [Related]
23. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
25. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
[TBL] [Abstract][Full Text] [Related]
26. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
27. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
31. Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus.
Robak E; Robak T; Wozniacka A; Zak-Prelich M; Sysa-Jedrzejowska A; Stepien H
Eur Cytokine Netw; 2002; 13(3):364-8. PubMed ID: 12231481
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension.
Cottone S; Mulè G; Nardi E; Vadalà A; Lorito MC; Guarneri M; Arsena R; Palermo A; Cerasola G
J Hypertens; 2007 Feb; 25(2):423-8. PubMed ID: 17211250
[TBL] [Abstract][Full Text] [Related]
34. [Laboratory indicators of endothelial involvement in rheumatic diseases associated with vasculitis in children].
Dolezalová P; Telekesová P; Nĕmcová D; Bĕlorová J; Kvasnicka J; Hoza J
Cas Lek Cesk; 2003; 142(10):615-9. PubMed ID: 14635427
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus.
El-Shafey EM; El-Nagar GF; El-Bendary AS; Sabry AA; Selim AG
Iran J Kidney Dis; 2008 Apr; 2(2):80-5. PubMed ID: 19377213
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
37. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
[TBL] [Abstract][Full Text] [Related]
38. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
39. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
40. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]